The juice of blood oranges and blonde oranges appears to down-regulate blood clotting.
Italian researchers have performed what they claim is the first in vivo study showing that orange juice supports healthy blood clotting.
Abnormal blood clotting is likely a factor in various heart conditions, such as angina and thrombosis. At the same time, flavonoid-rich fruits such as citrus have shown heart-healthy potential in clinical trials and epidemiological studies. But data supporting a link between these fruits and blood clotting specifically is lacking.
At the Catholic University in Campobasso, Italy, researchers assigned 17 healthy subjects to drink blood orange juice or blonde orange juice for four weeks daily and in crossover fashion. Some of the orange juice samples were enriched with anthocyanins, to determine if these flavonoids would be especially responsible for any cardiovascular changes.
Orange juice appeared to prolong blood-clotting times in subjects-an effect the researchers deem to be beneficial. The juices also increased blood presence of tissue factor pathway inhibitor (TFPI), which regulates normal blood clotting. The type of orange juice-blood orange or blonde orange-did not influence results, and neither did enrichment with anthocyanin flavonoids. For this reason, the researchers speculate that juice components other than anthocyanins are responsible for the effect of orange juice on blood clotting.
The researchers prepared blood orange juice with Moro, Tarocco, and Sanguinello orange varieties, and blonde orange juice with Valencia, Navel, and Belladonna varieties.
Robby Gardnerâ¨
Associate Editorâ¨
Nutritional Outlook magazineâ¨
robby.gardner@ubm.com
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.